Anastrozole Administration in Elderly Hypogonadal Men

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of the study is to assess the effects of sustained aromatase inhibitor therapy to reduce estrogen levels in elderly men with mild hypogonadism (a decreased level of sex hormones).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Massachusetts General Hospital
• Collaborator: National Institute on Aging (NIA)
• Treatments: Anastrozole

Criteria

Inclusion Criteria:

• Men ages 60 and older

• Serum testosterone between 150-300 ng/dL

• Symptoms suggestive of androgen deficiency